891842-81-2

Basic information

• Product Name: 6-(CYCLOPENTOXY)-2-BROMOPYRIDINE
• Synonyms: 6-(CYCLOPENTOXY)-2-BROMOPYRIDINE;2-bromo-6-cyclopentyloxypyridine
• CAS NO: 891842-81-2
• Molecular Formula: C10H12BrNO
• Molecular Weight: 242.11
• Mol File: 891842-81-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-(CYCLOPENTOXY)-2-BROMOPYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(CYCLOPENTOXY)-2-BROMOPYRIDINE(891842-81-2)
• EPA Substance Registry System: 6-(CYCLOPENTOXY)-2-BROMOPYRIDINE(891842-81-2)

Safety Data

• Hazardous Substances Data: 891842-81-2(Hazardous Substances Data)

Upstream product

• 626-05-1 2,6-Dibromopyridine 

Relevant articles and documents

BIARYL DERIVATIVE AS GPR120 AGONIST

The present invention relates to a biaryl derivative expressed by the chemical formula 1, a method for producing the biaryl derivative, a pharmaceutical composition comprising same, and use of same, the biaryl derivative expressed by the chemical formula 1, as a GPR120 agonist, promoting GLP-1 generation in the gastro-intestinal tract, reducing insulin resistance in the liver, muscles and the like from anti-inflammatory activity in the macrophage, pancreatic cells and the like, and allowing effective use in prevention or treatment of inflammation or metabolic diseases such as diabetes, complications from diabetes, obesity, non-alcoholic fatty liver disease, fatty liver disease, and osteoporosis.

TRIAZOLE DERIVATIVES HAVING ANTIFUNGAL ACTIVITY, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

A triazole derivative of formula 1 or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof is superior to the conventional antifungal drugs in antifungal activity against a wide spectrum of pathogenic fungi, and has advantageously low toxicity.

Heterocyclic compounds as inhibitors of factor VIIa

The present invention relates generally to compounds that inhibit serine proteases. In particular it is directed to novel heterocyclic compounds, or a stereoisomer or pharmaceutically acceptable salt, solvate, or prodrug form thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.